Molecular mechanisms and genetic factors contributing to the developmental dysplasia of the hip

Xiaoming Zhao1, Shuai Liu2, Zhonghua Yang3,4

  • 1Department of Pediatric Orthopaedics, Shenyang Orthopaedic Hospital, Shenyang, China.

Frontiers in Genetics
|August 19, 2024
PubMed

Insights

Developmental dysplasia of the hip (DDH) is a common neonatal condition. Genetic factors and gene variations are increasingly recognized as key contributors to DDH development and susceptibility.

Area of Science:

  • Genetics
  • Orthopedics
  • Developmental Biology

Background:

  • Developmental dysplasia of the hip (DDH) is the most common hip disease in neonates.
  • Accurate diagnosis and timely treatment are crucial for pediatric patients with DDH.
  • Genetic factors are increasingly implicated in the pathogenesis of DDH.

Purpose of the Study:

  • To review recent molecular mechanisms and genetic factors contributing to DDH.
  • To highlight the role of gene variation and heredity in DDH susceptibility.
  • To summarize findings from genetic studies in DDH.

Main Methods:

  • Genome-wide association studies (GWAS)
  • Genome-wide linkage analyses (GWLA)
  • Exome sequencing (ES)
  • Analysis of animal models with DDH phenotypes
  • Identification of noncoding RNAs and de novo gene variants

Main Results:

  • Numerous genes and single-nucleotide polymorphisms (SNPs) associated with DDH susceptibility have been identified.
  • DDH phenotypes are observed in animal models with specific genetic variants (e.g., CX3CR1, KANSL1, GDF5).
  • Noncoding RNAs and de novo gene variants contribute to DDH-related syndromes.

Conclusions:

  • Genetic factors play a significant role in the pathogenesis of DDH.
  • Advances in genetic research have enhanced the understanding of DDH etiology.
  • Further research into genetic mechanisms is essential for improving DDH diagnosis and treatment.

Related Concept Videos

Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
101.8K
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
Genetic Lingo01:11

Genetic Lingo

Overview
102.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
148